Clinical trialPhase 3
ACCLAIM-CTA
NCT07613294
Стартовал 02.06.2026: randomized double-blind placebo-controlled, N≈252, primary endpoint percent change in coronary noncalcified plaque volume.
No news refers to this card yet.
Scales
Identifiers
- NCT
- NCT07613294
Original sources
Details
- Phase
- Phase 3
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.